Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tagawa

Showing results (271-280 of 419) with videos related to

Pageof 42
Sort By:
Cancer|February 4, 2010
Anti-prostate-specific membrane antigen-based radioimmunotherapy for prostate cancerScott T Tagawa, Himisha Beltran, Shankar Vallabhajosula, et al.
Annals of Neurology|May 1, 1996
GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystoniaY Furukawa, M Shimadzu, A H Rajput, et al.
BJU International|August 2, 2008
Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomyScott T Tagawa, Tanya B Dorff, Leanne Rochanda, et al.
Frontiers in Oncology|August 30, 2013
Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody j591 in men with metastatic castration-resistant prostate cancerScott T Tagawa, Naveed H Akhtar, Anastasia Nikolopoulou, et al.
Lab on a Chip|December 22, 2009
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibodyJason P Gleghorn, Erica D Pratt, Denise Denning, et al.
BJU International|November 1, 2011
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)Daniel J Lee, Eugene K Cha, Justin M Dubin, et al.
Clinical Genitourinary Cancer|November 7, 2015
Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial CarcinomaBishoy Faltas, David M Goldenberg, Allyson J Ocean, et al.
Clinical and Experimental Pharmacology & Physiology|May 3, 2002
Central mechanisms underlying short- and long-term regulation of the cardiovascular systemR A L Dampney, M J Coleman, M A P Fontes, et al.
Surgery Today|January 1, 1997
Graft damage after a single lung transplantation for pulmonary hypertension in a rat modelS Yamamoto, K Kawahara, T Takahashi, et al.
American Journal of Clinical Oncology|October 1, 2010
A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981Scott T Tagawa, Matthew I Milowsky, Stephanie Jeske, et al.
Pageof 42

Showing results (271-280 of 419) with videos related to

Sort By:
Pageof 42
Cancer|February 4, 2010
Anti-prostate-specific membrane antigen-based radioimmunotherapy for prostate cancerScott T Tagawa, Himisha Beltran, Shankar Vallabhajosula, et al.
Annals of Neurology|May 1, 1996
GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystoniaY Furukawa, M Shimadzu, A H Rajput, et al.
BJU International|August 2, 2008
Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomyScott T Tagawa, Tanya B Dorff, Leanne Rochanda, et al.
Frontiers in Oncology|August 30, 2013
Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody j591 in men with metastatic castration-resistant prostate cancerScott T Tagawa, Naveed H Akhtar, Anastasia Nikolopoulou, et al.
Lab on a Chip|December 22, 2009
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibodyJason P Gleghorn, Erica D Pratt, Denise Denning, et al.
BJU International|November 1, 2011
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)Daniel J Lee, Eugene K Cha, Justin M Dubin, et al.
Clinical Genitourinary Cancer|November 7, 2015
Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial CarcinomaBishoy Faltas, David M Goldenberg, Allyson J Ocean, et al.
Clinical and Experimental Pharmacology & Physiology|May 3, 2002
Central mechanisms underlying short- and long-term regulation of the cardiovascular systemR A L Dampney, M J Coleman, M A P Fontes, et al.
Surgery Today|January 1, 1997
Graft damage after a single lung transplantation for pulmonary hypertension in a rat modelS Yamamoto, K Kawahara, T Takahashi, et al.
American Journal of Clinical Oncology|October 1, 2010
A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981Scott T Tagawa, Matthew I Milowsky, Stephanie Jeske, et al.
Pageof 42